Your browser doesn't support javascript.
loading
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.
Stuparu, Andreea D; Capri, Joseph R; Meyer, Catherine A L; Le, Thuc M; Evans-Axelsson, Susan L; Current, Kyle; Lennox, Mark; Mona, Christine E; Fendler, Wolfgang P; Calais, Jeremie; Eiber, Matthias; Dahlbom, Magnus; Czernin, Johannes; Radu, Caius G; Lückerath, Katharina; Slavik, Roger.
Afiliación
  • Stuparu AD; Atreca Inc., South San Francisco, California.
  • Capri JR; AstraZeneca, Chemical Biology Group, Waltham, Massachusetts.
  • Meyer CAL; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Le TM; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Evans-Axelsson SL; Department of Translational Medicine, Division of Urological Cancers, Skåne University Hospital Malmö, Lund University, Lund, Sweden.
  • Current K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Lennox M; School of Electronics, Electrical Engineering, and Computer Science, Queen's University Belfast, Belfast, United Kingdom.
  • Mona CE; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Fendler WP; Department of Urology, Institute of Urologic Oncology, UCLA, Los Angeles, California; and.
  • Calais J; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California.
  • Eiber M; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.
  • Dahlbom M; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Czernin J; Department of Urology, Institute of Urologic Oncology, UCLA, Los Angeles, California; and.
  • Radu CG; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California.
  • Lückerath K; Clinic for Nuclear Medicine, Technical University Munich, Munich, Germany.
  • Slavik R; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
J Nucl Med ; 62(7): 989-995, 2021 07 01.
Article en En | MEDLINE | ID: mdl-33277393
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: J Nucl Med Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: J Nucl Med Año: 2021 Tipo del documento: Article